Skip to main content
The Journal of Infectious Diseases logoLink to The Journal of Infectious Diseases
. 2012 Jul 16;206(9):1473–1478. doi: 10.1093/infdis/jis464

New Features of Invasive Candidiasis in Humans: Amyloid Formation by Fungi and Deposition of Serum Amyloid P Component by the Host

Kevin B Gilchrist 1, Melissa C Garcia 3, Richard Sobonya 1, Peter N Lipke 3, Stephen A Klotz 2
PMCID: PMC3570177  PMID: 22802434

Abstract

Background. Invasive candidiasis occurs in the gastrointestinal tract, especially in neutropenic patients. We were interested in determining whether invasive fungi formed amyloid in humans as they are known to do in vitro. We also sought to characterize the consequence(s) of such amyloid formation.

Methods. Tissue from 25 autopsy patients with invasive candidiasis of the gastrointestinal tract was stained with amyloidophilic dyes and for the presence of serum amyloid P component (SAP). Confirmation of the interaction of SAP and Candida was demonstrated using Candida albicans and mutants for amyloid formation.

Results. Amyloid was present on the cellular surface of fungi invading gut tissue. Moreover, SAP bound to the fungal cell walls, confirming the presence of amyloid. In vitro observations showed SAP bound avidly to fungi when amyloid formed in fungal cell walls. An unexpected result was the lack of host neutrophils in response to the invading fungi, not only in neutropenic patients but also in patients with normal or increased white blood counts.

Conclusions. We report the first demonstration of functional fungal amyloid in human tissue and the binding of SAP to invading fungi. It is postulated that fungal amyloid, SAP, or a complex of the proteins may inhibit the neutrophil response.


(See the editorial commentary by Pepys, on pages 1339–41.)

Misfolding of proteins in humans may lead to the formation and deposition of amyloid, which is often detrimental and destructive to vital organs. In many microbes, however, formation of amyloid appears to be purposeful and advantageous. Functional amyloids are found among Gram-positive bacteria, fungi, and even vertebrates [1]. For example, amyloid curli of Escherichia coli mediate biofilm formation and attachment to host proteins [2]. In Candida albicans and other yeasts, cell surface adhesins bind fungi to the host and also aggregate fungi to form colonies and biofilms [3, 4]. These adhesins, especially those of the C. albicans Als family, have functional amyloid-forming sequences [57]. In response to extension forces applied to the adhesins, they form nanometer-scale amyloid cell surface clusters of cell adhesion molecules called nanodomains [8, 9]. The amyloid nanodomains mediate tight, high avidity binding of the fungi to many ligands on host tissue and on other fungal cells [10].

Because functional amyloid within C. albicans cell surface adhesive proteins contributes to fungal cell adhesion and cell aggregation [5, 11], we wondered whether these protein aggregates could be found in invasive candidiasis in humans. Tissue from 25 patients with invasive gastrointestinal Candida infections was examined to determine whether amyloid was being formed in vivo at sites of infection. Because serum amyloid P component (SAP) binds to amyloid, we looked for the presence of SAP associated with functional amyloid of Candida or host amyloid AA deposition in response to invasive candidiasis.

The role of SAP in infections is not fully understood, and it has not been previously studied in candidiasis. Serum amyloid P component is a homopentamer with the protomers arranged with cyclic pentameric symmetry in a disc-like conformation [12, 13]. Each protomer has a mass of 25 462 Da, and the total mass of the protein is 127 310 Da. Serum amyloid P component binds to amyloid wherever it occurs in the body [14]. Aside from binding to amyloid, another function of SAP is believed to be binding to DNA when exposed during cellular apoptosis or necrosis, thus protecting host DNA from degradation and digestion and averting loss of self-tolerance [1518].

We found amyloid present on the surface of yeasts and filamentous forms of Candida but no evidence of amyloid AA. Serum amyloid P component, however, decorated the cell surface of all fungi in tissue. In vitro experiments demonstrated binding of SAP to Candida functional amyloid. We also found that the host neutrophil response to invasive fungi was minimal in almost all patients, including those with normal and elevated white blood cell counts. This is the first demonstration of candidal amyloid in human tissue and the first demonstration of SAP interacting with fungi in human disease. The results suggest that fungal amyloid and/or SAP may inhibit the host neutrophil response in invasive candidiasis.

MATERIALS AND METHODS

Human Tissue

Stored autopsy specimens from 25 patients with histological evidence of invasive candidiasis of the gastrointestinal tract were examined. Five of the patients died with evidence of postmortem candidemia [19]. Tissue blocks were cut thinly, deparaffinzed, and stained with hemotoxylin-eosin (H-E). Slides found to be positive for Candida species (presence of yeasts, pseudohyphae, and/or hyphae) were then stained with Gomori methamine silver (GMS), a polyclonal antibody to SAP (Biocare Medical) and antibody to amyloid AA (DakoCytomation). Congo red, thioflavin S, and thioflavin T stains for amyloid [20] were performed on the tissue as well. Multiple H-E stained slides of infected material were carefully examined for the presence of neutrophils and other inflammatory response cells in tissue adjacent to yeasts and filamentous forms. They were designated as minimal (none to almost none seen), moderate, or brisk (too numerous to count neutrophils). The microscopist was blinded to the patients' autopsy findings or peripheral white blood cell count. Thioflavin T fluorescence images were acquired on a Nikon Eclipse 90i confocal microscope with 408-nm excitation and 450-nm emission filters.

Fungi

Saccharomyces cerevisiae W303–1B with or without the wild-type ALS5 gene or a nonamyloid ALSV326N allele and C. albicans DAY286 were grown overnight in liquid media and washed extensively with phosphate-buffered saline [21]. Images of yeast in vitro were acquired using an Olympus BX51 fluorescence microscope.

SAP Interaction With Fungi

Fungal cells were also observed for binding of the SAP antibody or fungal cell binding of purified SAP. Yeast cells, 1 × 108, were washed 3 times with 3 ml tris-buffered saline, pH 7.4, with 4% BSA and 2 mM CaCl2. The cells were pelleted by centrifugation at 4000 RPM for 3 min and supernatants discarded. The cells were resuspended in 1 ml of the same buffer supplemented with SAP, 25 µg/ml (EMD Biosciences, San Diego, CA), and incubated for 1 hour at room temperature. The cells were washed twice with the above buffer. The cells were then incubated overnight with antibody to SAP (BioCare Medical, Concord, CA), washed with above buffer, and incubated with secondary antibody at 1:500 dilutions for 1.5 hours. Cells were washed 3× with the above buffer and wet mounts were visualized by microscopy.

RESULTS

Tissue from the gastrointestinal tract of 25 patients with invasive candidiasis stained with H-E and GMS demonstrated a mixture of yeasts and filamentous forms of fungi invading intestinal tissue (Figure 1A and 1B). Host response was often minimal to the fungi. This would be an expected finding in the case of neutropenic patients, but, surprisingly, patients with normal or increased white blood cell counts often had minimal or no infiltrating neutrophils. Eighteen patients had sufficient fungi observable on H-E stain to assess host response accurately on multiple sections. Eight patients were neutropenic at death, and of those, 7 had minimal and 1 had moderate numbers of neutrophils in proximity to the fungi. Ten patients died with normal or increased numbers of peripheral neutrophils: 3 of those patients had a brisk neutrophil response to the presence of fungi, 1 patient had a moderate response, and 6 patients had a minimal response to the presence of fungi, similar to the neutropenic patients (Table 1). The difference between patients who were neutropenic and those with normal or increased white blood cell counts was not significant (P = .21 by χ2 analysis). There was no evidence of neutrophils phagocytosing yeasts or attacking filamentous forms of the fungi as they are known to do in vitro [22].

Figure 1.

Figure 1.

Invasion of gastrointestinal tissue by Candida. A, Hematoxylin-eosin stain of intestinal tissue (×200). At the top of the figure, yeasts and filamentous forms of fungi staining reddish-blue (arrows) are present in an ulcerating lesion of the gastrointestinal mucosa with little inflammatory response. B, Gomori methenamine silver stain of intestinal tissue (×200). Yeast and filamentous forms of Candida stain black (arrows) and are seen within tissue, on the ulcerated mucosal tissue, and in the lumen of the gastrointestinal tract. C, Submucosal tissue of the gastrointestinal tract with invasive candidiasis stained for serum amyloid P component (×200). The protein is present on yeasts and filamentous forms of fungi, staining a reddish-brown (arrows).

Table 1.

Neutrophil Response to Invasive Candidiasis in Infected Gastrointestinal Tissue

Minimal Response Moderate Response Brisk Response Total
Neutropenic patients 7 1 0 8
Patients with normal or increased numbers of white blood cells 6 1 3 10

Eighteen patients had observable fungi on hematoxylin-eosin stain of the tissue with multiple sections available to judge the host response to the fungi. Neutropenia: <1500 neutrophils and band forms/μL; normal white blood cell count: 3400–10 400 cells/μL. There was no significant difference between the 2 groups (P = .21 by χ2 analysis).

All specimens showed heavy SAP deposition on fungal surfaces (Figure 1C) consistent with its binding to Candida functional amyloid. Staining for SAP was equal to that of GMS for highlighting fungi from the surrounding host tissue (compare Figure 1B and 1C). In vitro experiments showed that fungi with cell surface amyloid bound SAP. When yeasts were preincubated with SAP, the anti-SAP antibody bound weakly to C. albicans or to S. cerevisiae expressing the C. albicans adhesin Als5p. When functional amyloid formation was induced by aggregation (11), SAP bound extensively to C. albicans and S. cerevisiae expressing the adhesive protein Als5p (Figure 2) but not to S. cerevisiae not expressing Als5p (Figure 2A) or a nonamyloid mutant AlsrpV326N [21] (data not shown). Figure 2 shows the results of binding of SAP to yeast cells in vitro. SAP associated with C. albicans cells and with Als5p-expressing S. cerevisiae cells. There was extensive aggregation of the cells (Figure 2D, 2E, and 2H), and SAP binding to individual cells in the cellular aggregates (Figure 2B and 2F) in an annular pattern, as expected for surface binding. Some of the cells were fluorescent and others were not. In contrast, control S. cerevisiae cells not expressing the C. albicans adhesin were not stained (Figure 2I and 2J).

Figure 2.

Figure 2.

Binding of serum amyloid P (SAP) component to yeast in vitro. SAP, 25 µg/ml, was incubated with (AD) C. albicans; (EH) S. cerevisiae expressing Als5p on its surface; or (IL) S. cerevisiae transformed with empty vector only. The cells were washed and incubated with fluorescent antibody to SAP component. A, D, E, H, I, and L are brightfield images, and B, C, F, G, J, and K are the respective corresponding fluorescence images. There was no fluorescence in preparations of C. albicans or Als5p-expressing S. cerevisiae when SAP or primary antibody was omitted (data not shown).

Within large cellular aggregates of C. albicans and Als5p-expressing S. cerevisiae, there were also brightly stained precipitates, apparently aggregates of SAP (Figure 2C and 2G). These aggregates were both rare and small in preparations with nonexpressing control cells (Figure 2J and 2K). These results were consistent with SAP binding specifically to Als5p, accompanied by aggregation of the SAP itself. Saccharomyces cerevisiae expressing Als5p behaves phenotypically identical to C. albicans [23].

Thioflavin T staining demonstrated strong fluorescence on all fungi in the tissue (Figure 3), which is consistent with extensive amyloid formation on the fungal cell surfaces. The same pattern occurred with thioflavin S and Congo red (Figure 4A–C). Congo red, an excellent inhibitor of amyloid-dependent fungal cell aggregation [11], clearly bound to fungi in tissue, demonstrating apple green fluorescence with polarized light characteristic of amyloid (Figure 4D). A monoclonal antibody to amyloid AA did not detect any evidence of amyloid AA on the surface of the fungi.

Figure 3.

Figure 3.

Thioflavin T staining of tissue samples. Infected gut tissue (A) and uninfected spleen sample (B) were stained with 100 nM thioflavin T and imaged via confocal microscopy. Lower panels are bright light without stain.

Figure 4.

Figure 4.

Amyloid dye staining and birefringence of infected gastrointestinal tissue. Tissue was costained with 0.1% thioflavin S (A) and 0.1% Congo red (B) and analyzed for birefringence. Part (C) shows the 2 stains merged. Note apple-green birefringence denoting amyloid in (D).

DISCUSSION

This investigation demonstrates 3 novel findings with potential importance for the pathogenesis of invasive candidiasis. They are the presence of functional amyloid on fungal cell surface proteins in human disease, the binding of host SAP to invading fungi, and the possible inhibition of the host neutrophil response by the fungal amyloid–SAP complex.

Patients in this study died with invasive gastrointestinal candidiasis found at autopsy. Five of the patients had Candida species present in heart blood removed at postmortem [19], and it is possible that some of the intestinal lesions were the source of the candidemia. The H-E and GMS stains (Figure 1A and 1B) demonstrated fungi coursing through intestinal tissue with numerous yeasts and filamentous forms in close proximity to one another. There was little or no host reaction to the fungi, even among most of the patients with normal or elevated white blood cell counts (Table 1). There was no evidence of host cells directly attacking the fungi, and the lack of host cells did not appear to be related to the numbers of circulating neutrophils noted prior to death. Invasive candidiasis is often associated with neutropenia and a subsequent anatomical breach of normal host defenses [24, 25]. Indeed, gastrointestinal candidiasis in neutropenic patients has little or no acute inflammatory response [26], although neutrophils seem to predominate among host response cells in variable numbers depending upon the organ of the body infected [27]. Whereas neutropenia seems to predispose to invasive candidiasis, the role of innate immunity (other than neutrophils) is difficult to characterize. Many innate immune proteins interact with C. albicans and may serve a protective role against disease [28]. Serum amyloid P component has not heretofore been studied in candidiasis.

Candida albicans binds to peptides. This step leads to fungal cell aggregation [29] and culminates in the formation of amyloid in adhesin proteins on the cell surface [5]. Cellular aggregation is the preferred social mode of C. albicans [29] and an important step in the formation of mature biofilms that are rich in amyloid [21]. The adhesive proteins that form functional amyloid are expressed on all morphological forms of C. albicans [30]. Our work demonstrates the presence of amyloid on the surface of invasive yeasts, hyphae, and pseudohyphae by staining with Congo red, thioflavin S, or thioflavin T. Slifkin and Cumbie reported Congo red staining of Candida albicans in human tissue in 1988 but did not relate the finding to fungal amyloid [31], and more recently, Axelson et al were unable to show fungal amyloid in conjunction with cutaneous candidiasis [32].

Amyloid deposits in the human body are coated with SAP [33], and our work shows that SAP precipitated from its fluid phase in the circulation onto a nucleus of fungal amyloid. Microscopic sections show SAP coating yeasts and filamentous forms of Candida (Figure 1C). The process of fungal cellular aggregation puts tension on the cell surface adhesive proteins, leading to the spontaneous formation of amyloid [6, 8, 21]. Serum amyloid P component then deposits on the fungal functional amyloid (Figure 2). Other Candida species and fungi possess amyloidogenic sequences on their cell surface and have the potential to form amyloid as well [6].

Serum amyloid P component was found in some animal studies to inhibit the inflammatory response. For example, SAP bound to Streptococcus pyogenes and rough strains of E. coli, but it inhibited phagocytosis and reduced murine survival after intravenous challenge [34]. Similar to our findings of diminished inflammation in the presence of fungi, SAP was shown to inhibit macrophage function and reduce the inflammatory response to Aspergillus condia in the lungs [35]. Furthermore, it is interesting to note that amyloid by itself is characteristically “inert” and does not provoke a neutrophil reaction. For example, there is little or no host response to mature plaques (amyloid β) of Alzheimer's disease [36] or to infiltrating cardiac amyloid. It is possible that the amyloid formed by the fungi may inhibit the normal host neutrophil response. Or perhaps a complex of functional Candida amyloid and SAP may inhibit or retard the host neutrophil response. This may be a contributing factor in some patients with candidemia that is difficult to eradicate in spite of normal or increased numbers of peripheral neutrophils.

In conclusion, this report demonstrates the formation of amyloid by Candida species in human tissue. The microbial amyloid was associated with precipitation of SAP on the fungal cell surface. The presence of functional Candida amyloid and/or SAP may inhibit the host response to the fungi, perhaps by coating antigens that would be expected to elicit a strong host response.

Note

Potential conflicts of interest. All authors: No reported conflicts.

All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

References

  • 1.Otzen D, Nielsen PH. We seek them here, we find them there: functional bacterial amyloid. Cell Mol Life Sci. 2008;65:910–27. doi: 10.1007/s00018-007-7404-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Olsen A, Jonsson A, Normark S. Fibronectin binding mediated by a novel class of surface organelles on Eschereichia coli. Nature. 1989;338:652–5. doi: 10.1038/338652a0. [DOI] [PubMed] [Google Scholar]
  • 3.Dranginis A, Rauceo J, Coronado J, Lipke PN. A biochemical guide to yeast adhesins: glycoproteins for social and antisocial occasions. Microbiol Molec Biol Rev. 2007;71:282–94. doi: 10.1128/MMBR.00037-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Finkel J, Mitchell A. Genetic control of Candida albicans biofilm development. Nat Rev Microbiol. 2011;9:109–18. doi: 10.1038/nrmicro2475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Otoo H, Lee K, Qiu W, Lipke PN. Candida albicans Als adhesins have conserved amyloid-forming sequences. Eukaryot Cell. 2007;7:776–82. doi: 10.1128/EC.00309-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ramsook CB, Tan C, Garcia MC, et al. Yeast cell adhesion molecules have functional amyloid-forming sequences. Eukaryot Cell. 2010;9:393–404. doi: 10.1128/EC.00068-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Nobbs A, et al. Heterologous expression of Candida albicans cell wall-associated adhesins in Saccharomyces cerevisiae reveals differential specificities in adherence and biofilm formation and in binding oral Streptococcus gordonii. Eukaryot Cell. 2010;9:1622–34. doi: 10.1128/EC.00103-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Alsteens D, Garcia MC, Lipke PN, Dufrene YF. Force-induced formation and propagation of adhesion nanodomains in living fungal cells. Proc Natl Acad Sci U S A. 2010;107:20744–9. doi: 10.1073/pnas.1013893107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Garcia MC, Lee JT, Ramsook CB, Alsteens D, Dufrene YF, Lipke PN. A role for amyloid in cell aggregation and biofilm formation. PLoS One. 2011;6:el17632. doi: 10.1371/journal.pone.0017632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lipke PN, Garcia MC, Alsteens D, Ramsook CB, Klotz SA, Dufrene YF. Strengthening relationships: amyloids create adhesion nanodomains in yeasts. Trends Microbiol. 2011;20:59–65. doi: 10.1016/j.tim.2011.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Rauceo JM, Gaur NK, Klotz SA, Edwards JEJ, Lee K, Lipke PN. Global cell-surface conformational shift mediated by a Candida albicans adhesin. Infect Immun. 2004;72:4948–55. doi: 10.1128/IAI.72.9.4948-4955.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Pepys MB, Dash AC. Isolation of amyloid P component (protein AP) from normal serum as a calcium-dependent binding protein. Lancet. 1977;1:1029–31. doi: 10.1016/s0140-6736(77)91260-0. [DOI] [PubMed] [Google Scholar]
  • 13.Pepys MB, Dash AC, Fletcher TC, Richardson N, Munn EA, Feinstein A. Analogues in other mammals and in fish of human plasma proteins, C-reactive protein and amyloid P component. Nature. 1978;273:168–70. doi: 10.1038/273168a0. [DOI] [PubMed] [Google Scholar]
  • 14.Pepys MB, Rademacher TW, Amatayakul-Chantler S, et al. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc Natl Acad Sci U S A. 1994;91:5602–6. doi: 10.1073/pnas.91.12.5602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Pepys MB, Butler PJG. Serum amyloid P component is the major calcium-dependent specific DNA binding protein in the serum. Biochem Biophys Res Commun. 1987;148:308–13. doi: 10.1016/0006-291x(87)91111-9. [DOI] [PubMed] [Google Scholar]
  • 16.Butler PJG, Tennent GA, Pepys MB. Pentraxin-chromatin interactions: serum amyloid P component specifically displaces H1-type histones and solubilizes native long chromatin. J Exp Med. 1990;172:13–8. doi: 10.1084/jem.172.1.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Bickerstaff MC, Botto M, Hutchinson WL, et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med. 1999;5:694–7. doi: 10.1038/9544. [DOI] [PubMed] [Google Scholar]
  • 18.Gillmore JD, Hutchinson WL, Herbert J, et al. Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination? Immunol. 2004;112:255–64. doi: 10.1111/j.1365-2567.2004.01860.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Thorn JL, Gilchrist KB, Sobonya RE, Gaur NK, Lipke PN, Klotz SA. Postmortem candidemia: marker of disseminated disease. J Clin Pathol. 2010;63:337–40. doi: 10.1136/jcp.2009.070607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Puchtler H, Waldrop FS, Meloan SN. A review of light, polarization and fluorescence microscopic methods for amyloid. Appl. Pathol. 1985;3:5–17. [PubMed] [Google Scholar]
  • 21.Garcia MC, Lee JT, Ramsook CB, Alsteens D, Dufrene YF, Lipke PN. A role for amyloid in cell aggregation and biofilm formation. PLoS One. 2011;6:e17632. doi: 10.1371/journal.pone.0017632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Diamond R. Fungal surfaces: effects of interactions with phagocytic cells. Rev Infect Dis. 1988;10:S428–31. doi: 10.1093/cid/10.supplement_2.s428. [DOI] [PubMed] [Google Scholar]
  • 23.Gaur N, Klotz S, Henderson R. Overexpression of the Candida albicans ALA1 gene in Saccharomyces cerevisiae results in aggregation following attachment of yeast cells to extracellular matrix proteins, adherence properties similar to those of Candida albicans. Infect Immun. 1999;67:6040–7. doi: 10.1128/iai.67.11.6040-6047.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Prescott RJ, Harris M, Banerjee SS. Fungal infections of the small and large intestine. J Clin Pathol. 1992;45:806–11. doi: 10.1136/jcp.45.9.806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Pappas P. Invasive candidiasis. Infect Dis Clinics of North Am. 2006;20:485–506. doi: 10.1016/j.idc.2006.07.004. [DOI] [PubMed] [Google Scholar]
  • 26.Walsh T, Merz W. Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis. Am J Clin Pathol. 1986;85:498–502. doi: 10.1093/ajcp/85.4.498. [DOI] [PubMed] [Google Scholar]
  • 27.Lionakis M, Lim J, Lee C, Murphy P. Organ-specific innate immune responses in a mouse model of invasive candidiasis. J Innate Immun. 2011;3:180–99. doi: 10.1159/000321157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.van de Veerdonk FL, Kullberg B-J, Netea MG. Pathogenesis of invasive candidiasis. Curr Opin Crit Care. 2010;16:453–9. doi: 10.1097/MCC.0b013e32833e046e. [DOI] [PubMed] [Google Scholar]
  • 29.Klotz SA, Lipke PN, Méndez-Vilas A. Current research, technology, and education topics in applied microbiology and microbial biotechnology. Vol. 2. 2010. The perfect adhesive; pp. 834–44. [Google Scholar]
  • 30.Gaur NK, Klotz SA. Expression, cloning, and characterization of a Candida albicans gene, ALA1, that confers adherence properties upon Saccharomyces cerevisiae for extracellular matrix proteins. Infect Immun. 1997;65:5289–94. doi: 10.1128/iai.65.12.5289-5294.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Slifkin M, Cumbie R. Congo red as a fluorochrome for the rapid detection of fungi. J Clin Microbiol. 1988;26:827–30. doi: 10.1128/jcm.26.5.827-830.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Axelson G, Giorgadze T, Youngberg G. Evaluation of the use of Congo red staining in the differential diagnosis of Candida vs various other yeast-form fungal organisms. J Cutan Pathol. 2008;35:27–30. doi: 10.1111/j.1600-0560.2007.00769.x. [DOI] [PubMed] [Google Scholar]
  • 33.Pepys MB. Pathogenesis, diagnosis and treatment of systemic amyloidosis. Phil Trans R Soc Lond. 2001;356:203–211. doi: 10.1098/rstb.2000.0766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Noursadeghi M, Bickerstaff MC, Gallimore JR, Herbert J, Cohen J, Pepys MB. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. PNAS. 2000;97:14584–89. doi: 10.1073/pnas.97.26.14584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Moreira A, Cavassani K, Hullinger R, et al. Serum amyloid P attenuates M2 macrophage activation and protects against fungal spore-induced allergic airway disease. J Allergy Clin Immunol. 2010;126:712–21. doi: 10.1016/j.jaci.2010.06.010. [DOI] [PubMed] [Google Scholar]
  • 36.Castellani R, Lee H, Zhu X, Perry G, Smith M. Alzheimer's disease pathology as a host response. J Neuropatholo Exp Neurol. 2008;67:523–31. doi: 10.1097/NEN.0b013e318177eaf4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Infectious Diseases are provided here courtesy of Oxford University Press

RESOURCES